echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > Geneyork pharmaceutical company announced that prednisone tablets have officially entered the U.S. market

    Geneyork pharmaceutical company announced that prednisone tablets have officially entered the U.S. market

    • Last Update: 2020-02-04
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Recently, Geneyork Pharmaceutical Co., Ltd and Lannett Pharmaceutical Co., Ltd of the United States began to jointly sell 1 mg, 2.5 mg, 5 mg, 10 mg, 20 mg, and 50 mg generic prednisone tablets in the United States market in a total of 6 specifications The drug is a kind of hormone drug, mainly used in allergic and autoimmune inflammatory diseases According to IMS data, sales in the United States in 2018 were $121 million With so many specifications and large quantities of products put on the U.S market, it is an important milestone for China to enter the international leading position in the field of steroids.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.